IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 144 filers reported holding IMMUNITYBIO INC in Q4 2022. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,948,160 | -39.7% | 1,152,757 | -0.8% | 0.00% | -100.0% |
| Q2 2023 | $3,229,523 | +118.6% | 1,161,699 | +43.1% | 0.00% | – |
| Q1 2023 | $1,477,281 | -64.3% | 811,693 | -0.4% | 0.00% | -100.0% |
| Q4 2022 | $4,133,434 | +2.6% | 815,273 | +0.5% | 0.00% | 0.0% |
| Q3 2022 | $4,030,000 | +43.5% | 810,889 | +7.4% | 0.00% | 0.0% |
| Q2 2022 | $2,808,000 | -25.0% | 754,874 | +13.1% | 0.00% | 0.0% |
| Q1 2022 | $3,745,000 | -10.0% | 667,370 | -2.5% | 0.00% | 0.0% |
| Q4 2021 | $4,162,000 | -66.0% | 684,527 | -45.6% | 0.00% | -50.0% |
| Q3 2021 | $12,257,000 | -36.4% | 1,258,399 | -6.7% | 0.00% | -33.3% |
| Q2 2021 | $19,259,000 | +68.4% | 1,348,695 | +179.9% | 0.00% | +50.0% |
| Q1 2021 | $11,439,000 | – | 481,807 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Winning Points Advisors, LLC | 251,556 | $1,387,000 | 1.70% |
| ORACLE INVESTMENT MANAGEMENT INC | 315,322 | $1,567,000 | 0.89% |
| HARBOURVEST PARTNERS LLC | 335,709 | $1,668,000 | 0.54% |
| ALLEN HOLDING INC /NY | 687,571 | $3,417,000 | 0.54% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $479,000 | 0.21% |
| SHEETS SMITH WEALTH MANAGEMENT | 207,926 | $1,033,000 | 0.17% |
| Clearwater Capital Advisors, LLC | 185,911 | $924,000 | 0.13% |
| WEALTH EFFECTS LLC | 28,500 | $142,000 | 0.09% |
| Virtus ETF Advisers LLC | 35,048 | $174,000 | 0.07% |
| Vident Investment Advisory, LLC | 195,127 | $969,000 | 0.03% |